Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - TOTAL RECEIVABLES
Total Receivables REGN - Regeneron Pharmaceuticals, Inc.
6.21 B
LAST VALUE
7.97%
2 YEAR CAGR
24.22%
5 YEAR CAGR
20.33%
10 YEAR CAGR